What they found: Favorable safety profile , no serious adverse events at doses up to 100 g/kg Preliminary efficacy signals positive The program stopped before Phase 3 for unknown commercial reasons (the program passed through several sponsor rotations and no one ultimately carried it through) Why it matters: These are the only published clinical data in humans that we have
She was cautiously optimistic about Trumps plans to broaden access, though she emphasized that patients also needed guidance to improve their nutrition and to exercise
(3) Drug Delivery Innovation: a
News Release November 20, 2001 ConsumerLab.com finds fish oil supplements free of mercury, but 30% lacking in key ingredient Test results of omega-3 fatty acid (EPA and DHA) products released today WHITE PLAINS, NY November 20, 2001 ConsumerLab.com, an independent evaluator of dietary supplements and nutrition products, released results today of its Product Review of Omega-3 Fatty Acids (EPA & DHA) from Fish/Marine Oils
Knop, F.K
Endocrine Disorders in Kidney Disease , 127-138